All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Exempt, with results | 2004-004684-30 | Phase I/II Studie zur Immunisierung mit dem Peptid MAGE-3.A1 gemischt mit der immunologischen Adjuvans CpG 7909 bei Patienten mit metastasiertem Melanom | not-yet-due | |
Exempt, with results | 2004-004686-15 | Phase I/II study of immunization with multiple peptides mixed with the immunological adjuvant CpG 7909 in HLA-A2 patients with metastatic melanoma ... | not-yet-due | |
Reported results | 2004-005118-35 | Randomized double-blind phase II trial of NY-ESO-1 ISCOMATRIX and ISCOMATRIXadjuvant alone in patients with resected stage III or IV malignant melanoma | 2008-07-10 | due-trials |
Reported results | 2009-017885-22 | Phase II Study of ADI-PEG 20 in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer | 2013-06-24 | due-trials |
Exempt, with results | 2015-005298-19 | Phase 1/2 Study of anti-PD-L1 in Combination with Chemo(radio)therapy for Oesophageal Cancer | not-yet-due |